Sometimes stepping back isn’t a setback — it’s a reset.
Current News
Curated science + real conversations = faster, safer implementation on Monday.
A hopeful reflection on RP1’s FDA setback and the future of intratumoral therapy in melanoma.
News broke today that President Joe Biden has been diagnosed with stage IV (metastatic) prostate cancer. As an oncologist, this is not just a headline—it becomes an important teaching moment for how we evaluate and manage newly diagnosed metastatic prostate cancer. With the public eye now focused, many are likely wondering: what does this diagnosis …
If you’ve ever picked up a brightly colored candy or a strawberry-flavored treat, chances are you’ve encountered Red Dye No. 3, a synthetic food dye known for its vibrant hue. Despite its eye-catching appeal, Red Dye No. 3 has long been surrounded by controversy due to potential health risks. Recently, the U.S. Food and Drug …
Prenatal cell-free DNA (cfDNA) testing has revolutionized obstetrics, serving primarily to screen for fetal genetic abnormalities. Similarly, in oncology, circulating tumor DNA (ctDNA) has become a vital tool for detecting minimal residual disease in colorectal cancer after resection and monitoring responses to immunotherapy. However, groundbreaking research published in the December 2024 issue of The New England …
On December 2, 2024, Novocure announced positive results from the Phase 3 PANOVA-3 trial, which evaluated Tumor Treating Fields (TTFields) therapy in combination with gemcitabine and nab-paclitaxel for unresectable, locally advanced pancreatic cancer. The trial demonstrated a statistically significant improvement in overall survival (OS), offering a new potential option for this challenging patient population. However, …
In a recent and courageous announcement, actor James Van Der Beek, known for roles in Dawson’s Creek and Varsity Blues, revealed his diagnosis of colorectal cancer. At age 47, Van Der Beek shared that he has been managing this diagnosis privately, taking steps towards treatment with the support of his family. While the specifics indicate …
In recent years, Johnson & Johnson (J&J), a global healthcare company, has faced mounting legal challenges over allegations that its talcum powder products have caused cancers, including mesothelioma and ovarian cancer. Thousands of lawsuits have been filed, claiming that prolonged use of J&J’s talc-based baby powder led to serious health consequences due to the presence …
Hope for Advanced Bladder Cancer Bladder cancer is often like an unwelcome party crasher, popping up when least expected and causing considerable distress. Yet, in the realm of oncology, we are constantly seeking new ways to send such unwelcome guests packing. Today, I am thrilled to share some exciting news about a promising new approach …